London-based HealthTech firm Thriva has secured £6m in funding.

The Series A round, from a range of investors including Pembroke VCT and Guinness Asset Management, takes the total raised by Thriva to £7.5m since its launch in 2016.

The 35-strong company, which was founded by Hamish Grierson, Eliot Brooks and Tom Livesey, said it continues to grow 100 per cent year-on-year and has expanded its team in the company’s headquarters.

It was recently showcased as one of our 101 HealthTech Innovators.

The firm aims to help its customers better understand and keep track of their heath with at-home testing kits which analyse vitamins, minerals, hormone function and indicators of heart disease and diabetes.

It then suggest ways to improve these results with advice and a series of supplements.

“Most people are still not aware that companies like Thriva exist,” said Hamish Grierson, co-founder and CEO of Thriva.

“That is something we want to change as we build towards a truly consumer-led future of health.

“Our mission remains the same: To provide anybody with profound control over their own wellbeing.

“Swathes of the population are already proactively seeking improved health, and are waking up to the fact that it's within their gift to understand and control.

“It’s a system we see as working in tandem with organisations like the NHS, which offer a crucial service for people at the point of need when sick and/or serious care is needed.”

Ashley Abrahams, Investment Manager at investor Guinness Asset Management added: “We are excited about the potential of the strong management team to continue and enhance the impressive growth in a rapidly developing market where Thriva can become the dominant player and we look forward to working with them going forwards.”